Volume | 76,275 |
|
|||||
News | - | ||||||
Day High | 1.77 | Low High |
|||||
Day Low | 1.50 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Holdco Nuvo Group DG Ltd | NUVO | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
1.75 | 1.50 | 1.77 | 1.67 | 1.77 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
470 | 76,275 | US$ 1.65 | US$ 125,862 | - | 1.17 - 8.25 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:51:36 | 1 | US$ 1.58 | USD |
Holdco Nuvo Group DG Ltd Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
55.55M | 33.26M | - | 0 | -5.34M | -0.16 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Holdco Nuvo Group DG News
Date | Time | Source | News Article |
---|---|---|---|
5/09/2024 | 07:30 | GlobeNewswire Inc. | Nuvo Group Adds HealthTech Veteran Adriana Machado to Board.. |
5/07/2024 | 20:53 | Edgar (US Regulatory) | Form 20-F - Annual and transition report of foreign private.. |
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NUVO Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.29 | 1.85 | 1.17 | 1.59 | 447,712 | 0.28 | 21.71% |
1 Month | 1.75 | 2.04 | 1.17 | 1.57 | 171,654 | -0.18 | -10.29% |
3 Months | 6.30 | 8.25 | 1.17 | 4.73 | 1,746,604 | -4.73 | -75.08% |
6 Months | 6.30 | 8.25 | 1.17 | 4.73 | 1,746,604 | -4.73 | -75.08% |
1 Year | 6.30 | 8.25 | 1.17 | 4.73 | 1,746,604 | -4.73 | -75.08% |
3 Years | 6.30 | 8.25 | 1.17 | 4.73 | 1,746,604 | -4.73 | -75.08% |
5 Years | 6.30 | 8.25 | 1.17 | 4.73 | 1,746,604 | -4.73 | -75.08% |
Holdco Nuvo Group DG Description
Nuvo is leading a transformation in pregnancy care by providing clinicians and expectant mothers with access to medically-necessary remote pregnancy monitoring anytime, anywhere. Nuvo¿s INVU¿ platform is an FDA-cleared remote pregnancy monitoring and management system. It enables the delivery of remote non-stress tests (NSTs) and maternal and fetal heart rate monitoring, while pioneering new data-driven personalized pathways that can improve future health outcomes. INVU is being used by leading health providers and research institutions across the US and Israel. Nuvo will continue to expand the footprint of sales in the US and Israel and plans to introduce the product in Europe in 2024 following the hoped for granting of the CE mark in 2024 to provide remote access and insights not previously deemed possible. |